Motomi Mori MS, PhD, MBAProfessor Biostatistics
Motomi “Tomi” Mori is a professor of biostatistics in the School of Public Health, a professor in the OHSU School of Medicine’s Department of Medical Informatics & Clinical Epidemiology and director of the Biostatistics Shared Resource at OHSU’s Knight Cancer Institute.
She has published over 130 articles and has 27 years of experience in cancer research. Her current research interest includes clinical trial designs for molecularly targeted agents, biomarker validation and evaluation of personalized medicine in treatment and prevention.
Prior to her time at OHSU and the School of Public Health, Mori was a research assistant professor in the Department of Biostatistics at the University of Washington and a lead biostatistician for the Huntsman Cancer Institute at the University of Utah. She was head of the Division of Biostatistics in the Department of Public Health & Preventive Medicine from 2004 to 2014.
B.A., University of Montana, 1982
M.S., University of Iowa, 1985
Ph.D., University of Iowa, 1989
M.B.A., OHSU-PSU, 2016
Awards and Honors
- 2010, Fellow of the American Statistical Association
- 2005, Outstanding Alumni Award, University of Iowa
- OHSU Knight Cancer Institute (NIH/NCI P30CA069533), Brian Druker (PI), 07/01/2017-06/30/2022
- BEAT-AML: Personalized Medicine for AML Based on Functional Genomics (Leukemia & Lymphoma Society), Brian Druker (PI), 05/01/2013-06/30/2018
- Community-Based HIT Tools for Cancer Screening and Health Insurance Program (NIH/NCI R01CA181452), Jennifer DeVoe (PI), 7/1/2014-6/30/2019
- Proteogenomic Analysis of Drug Response and Resistance in AML to Guide Targeted Therapies (NIH/NCI U01CA214116), Karin Rodland/Brian Druker (PIs), 06/08/2017-06/07/2018